Patents for A61P 17 - Drugs for dermatological disorders (106,455)
01/2003
01/16/2003US20030012773 Diaper dermatitis preventative medication and a method for making and using same
01/16/2003US20030012749 Applying a preparation comprising water, urea and a film-forming agent to remove and treat diseased nails affected by onychomycosis
01/16/2003US20030012741 Process for the preparation of micronised collagen, and its therapeutic applications
01/16/2003DE20215776U1 Alcohol-free cosmetic, for use in piercing, contains dexpanthenol, chlorhexidine gluconate and glycerol
01/16/2003CA2453075A1 Drug metabolizing enzymes
01/16/2003CA2452686A1 Arylamines for the treatment of conditions associated with gsk-3
01/16/2003CA2452609A1 Thiazole benzamide derivatives and pharmaceutical compositions for inhibiting cell proliferation, and methods for their use
01/16/2003CA2452603A1 Isoxazolyl-pyrimidines as inhibitors of src and lck protein kinases
01/16/2003CA2452597A1 Piperidine derivatives useful as modulators of chemokine receptor activity
01/16/2003CA2452372A1 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent
01/16/2003CA2452241A1 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
01/16/2003CA2451749A1 Novel immunomodulating compounds
01/16/2003CA2451738A1 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals using 2-amino-2'-deoxyadenosine
01/16/2003CA2451472A1 Hair lotion stimulating hair growth
01/16/2003CA2448913A1 Sulfone containing bicyclic aromatic ring compounds, their preparation and use as nicotinic acetyl-chloine receptors
01/15/2003EP1275643A1 Vitamin d derivatives
01/15/2003EP1275638A1 Combination therapy for the treatment of immunological disorders
01/15/2003EP1275396A2 Use of angiotensin II fragments and analogs thereof in tissue repair
01/15/2003EP1275372A1 Cosmetic or dermatological composition comprising a N-acylaminoamide derivative and a metalloproteinase inhibitor
01/15/2003EP1274852A2 Targeted vaccine delivery systems
01/15/2003EP1274849A2 Protein phosphatases
01/15/2003EP1274834A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
01/15/2003EP1274726A2 Therapeutic compounds and methods for modulating v3, a versican isoform
01/15/2003EP1274720A1 Albumin fusion proteins
01/15/2003EP1274719A2 Albumin fusion proteins
01/15/2003EP1274712A1 Novel flavone glycoside derivatives for use in cosmetics, pharmaceuticals and nutrition
01/15/2003EP1274710A2 Novel heteroaryl-diazabicycloalkanes
01/15/2003EP1274709A1 Salts of bicyclic, n-acylated imidazo-3-amines and imidazo-5-amines
01/15/2003EP1274705A1 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
01/15/2003EP1274701A1 Chemical compounds
01/15/2003EP1274697A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp)
01/15/2003EP1274694A1 Novel compounds
01/15/2003EP1274692A1 Quinazoline compounds
01/15/2003EP1274473A2 Antimicrobial bioabsorbable materials
01/15/2003EP1274455A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions
01/15/2003EP1274450A2 Cytokine uses; compositions; methods
01/15/2003EP1274446A1 Polysaccharidic esters of n-derivatives of glutamic acid
01/15/2003EP1274428A2 Il-8 receptor antagonists
01/15/2003EP1274424A1 Compounds and methods
01/15/2003EP1274420A1 Microbial inhibitory compositions
01/15/2003EP1274417A2 Treatment of movement disorders with metabotropic glutamate receptor antagonists
01/15/2003EP1274416A1 Dermatological use and a dermatological preparation
01/15/2003EP1274415A2 Il-8 receptor antagonists
01/15/2003EP1274413A2 Il-8 receptor antagonists
01/15/2003EP1274408A2 Use of natural chrysanthone compounds having antiangiogenic activity
01/15/2003EP1274407A2 Uses of ppar-gamma agonists in neutrophil-induced diseases
01/15/2003EP1169317B1 Triarylimidazoles
01/15/2003EP0925287B1 Heterocyclic metalloprotease inhibitors
01/15/2003EP0912572B1 Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
01/15/2003EP0729468B1 Non-peptide tachykinin receptor antagonists
01/15/2003EP0649412B1 Pharmaceutical pyridine compounds
01/15/2003EP0584347B1 Enantiomeric hydroxylated xanthine compounds
01/15/2003CN1391605A Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
01/15/2003CN1391576A Androgen receptor modulator compounds and methods
01/15/2003CN1391572A Oxazolidinones having sulfoximine functionality and their use as antimicrobial agents
01/15/2003CN1391570A Phenyl-and pyridyl-tetrahydro-pyridines having TNF inhibiting activity
01/15/2003CN1391557A 6-position substituted indoline, production and use thereof as medicament
01/15/2003CN1391556A IL-8 receptor antagonists
01/15/2003CN1391479A Medicament for inducing tolerance
01/15/2003CN1391475A Optically active isomers of ketotifen and therapeutically active metabolites thereof
01/15/2003CN1391473A VLA-4 inhibitor compounds
01/15/2003CN1391467A Method of microencapsulation
01/15/2003CN1391458A Use of nonimmunosuppressive cyclosporin derivatives for hair growth
01/15/2003CN1390602A Extract of Jiaotuo conch or its mycelium and preparing process and applicatino of its medicine
01/15/2003CN1390595A Process for preparing Chinese medicine as skin lotion
01/15/2003CN1390593A Chinese-medicinal ointment for treating burn
01/15/2003CN1390592A Powdered medicine for replenishing vital essence and beautifying face and its preparing process
01/15/2003CN1390591A Chinese-medicinal liniment fr treating dermatopathy
01/15/2003CN1390589A Quick-acting antalgesic-antipruritic tincture
01/15/2003CN1390573A Chinese patent medicine for treating leukodema
01/15/2003CN1390571A Chinese medicine for treating burn and scald
01/15/2003CN1390570A Liquid medicine for treating tinear
01/15/2003CN1390562A Chinese medicine for treating burn and scald and its preparing process
01/15/2003CN1390556A Face beautifying powder 'Sanqing'
01/15/2003CN1390555A Medicine for treating ultraviolet burn
01/15/2003CN1390549A Medicine for treating beriberi
01/15/2003CN1390548A Antipruritic liquid
01/15/2003CN1098849C 噻唑衍生物 Thiazole derivatives
01/15/2003CN1098691C Propolis honey and its preparing process
01/15/2003CN1098686C Use of xanthine derivatives for reducing pathological hyper-reactivity of eosinophilic granulocytes, xanthine compounds and process for producing them
01/15/2003CN1098685C Rifampin film and preparing method and use thereof
01/14/2003US6506912 Method of locking 1α-OH of vitamin D compounds in axial orientation
01/14/2003US6506891 Cell surface molecule-induced macrophage activation
01/14/2003US6506874 Hypoglycemic agents; obesity, nervous system, cardiovascular, and kidney disorder treatment
01/14/2003US6506802 Disulfide derivatives useful for treating allergic diseases
01/14/2003US6506796 Cosmetically or therapeutically treating diseases or disorders in cell populations whose pathology is linked to an inadequate rate of apoptosis by administering a therapeutically effective amount of
01/14/2003US6506779 Acetylene derivatives as anti-inflammatory/analgesic agents
01/14/2003US6506773 Hydroxamic and carboxylic acid derivatives
01/14/2003US6506750 Morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
01/14/2003US6506748 Aromatic heterocyclic compounds as antiinflammatory agents
01/14/2003US6506740 Compounds that can be substituted at the 7, 8, and/or 9 positions and methods for preparing the 4- dedimethylamino tetracycline compounds. Other tetracycline compounds are the 4-dedimethylaminotetracycline derivatives with an oxime
01/14/2003US6506591 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
01/14/2003US6506555 Use of HIV protease inhibiting compounds
01/14/2003US6506383 Methods of suppressing immune responses to transplanted tissues and organs with gp39-specific antibodies
01/14/2003CA2288760C Ascorbyl-phosphoryl-cholesterol
01/14/2003CA2222303C Use of at least one no synthase inhibitor for treating sensitive skin
01/14/2003CA2056322C Ginkgo biloba acting as alpha-2-blocker slimming compound
01/09/2003WO2003003004A2 Method for identifying compounds the specifically deplete mast cells
01/09/2003WO2003002756A1 Fkbp51/52 and cyp40-mediated mammalian hair growth
01/09/2003WO2003002722A2 T cell regulatory genes and methods of use thereof